All COVID-19 updates and resources can be found on the CF Canada website.

Skip To Content
Volunteer Advocate


All media inquiries can be directed to or by calling 1-800-378-2233.

Cystic Fibrosis Canada Tells Government to Halt Implementation of Regulatory Changes
February 21, 2020

TORONTO (February 21, 2020) — Cystic Fibrosis Canada has called on the federal government to halt implementation of regulatory changes to the Patented Medicines Price Review Board (PMPRB). Read our submission to the PMPRB, titled Submission on Protecting Canadians from Excessive Drug Prices: Proposed Guidelines to the Patented Medicines Regulations.

Read More
Holiday wishes are different for people living with cystic fibrosis
November 28, 2019

TORONTO (November 28, 2019) - Cystic Fibrosis Canada is launching their fourth annual Year End campaign featuring four CF families and their wishes for the holiday season. The campaign helps raise vital funds for CF research, care and advocacy initiatives to help Canadians with CF live longer and healthier lives. The campaign will run from November 28th to December 31st, and all donations made on December 3rd (Giving Tuesday) will be matched up to $30,000.

Read More
Cystic Fibrosis Canada asks Canadians to do whatever it takes
October 2, 2019

TORONTO (October 2, 2019) – Cystic Fibrosis Canada is asking Canadians and candidates to do whatever it takes to improve access to potentially life-changing medicines for rare diseases. Through an online petition during the 2019 federal election season, Cystic Fibrosis Canada is calling on candidates to prioritize the creation of a rare disease strategy to improve access to drugs for rare diseases.

Read More
Siemens celebrates $2 million in donations to Cystic Fibrosis Canada
June 27, 2019

TORONTO (June 27, 2019) – Today, Siemens celebrates the milestone of $2 million in accumulative giving over the course of its more than 20 year partnership with Cystic Fibrosis Canada. Every June, the company runs a fundraising campaign to support cystic fibrosis (CF) research, advocacy and care. 

Read More
May 1, 2019

TORONTO (May 1, 2019) – Cystic Fibrosis Canada is celebrating the 15th anniversary of its signature fundraising event, The Walk to Make Cystic Fibrosis History. Each year, the Walk is held on the last Sunday in May, Cystic Fibrosis Awareness Month. This year’s Walk will take place on Sunday, May 26 in over 70 communities across Canada.

Read More
Inkbox Releases Cystic Fibrosis Inspired Temporary Tattoo Collection
March 5, 2019

Cystic Fibrosis Canada is excited to announce that temporary tattoo company inkbox has released a collection inspired by cystic fibrosis (CF) and the upcoming film Five Feet Apart. 50 percent of sales will be donated to the Cystic Fibrosis Individualized Therapy program (CFIT), a research partnership with SickKids.

Read More
February 27, 2019

TORONTO (February 27, 2019) – The governments of Saskatchewan, Alberta and Ontario have announced prescribing criteria for pediatric patients to qualify for public coverage of ORKAMBI on an exceptional, case-by-case basis. This announcement is the result of diligent advocacy work by Cystic Fibrosis Canada and the Canadian cystic fibrosis community. The decision comes three years after Health Canada approved the medication for use in Canada. 

Read More
Cystic Fibrosis Canada Asks the Tough Questions
November 27, 2018

TORONTO (November 27, 2018) ? With the launch of its holiday giving campaign, Tough Questions, Cystic Fibrosis Canada (CF Canada) is asking Canadians to help answer the questions that people with cystic fibrosis (CF) can’t. The fundraising campaign will feature five Canadian families and individuals affected by the fatal disease and demonstrate how a simple question can hurt to hear when the future is unknown. But Canadians can help because the answer to each question is in a cure.

Read More
Cystic Fibrosis Canada’s position on cannabis in the treatment of cystic fibrosis
October 17, 2018

TORONTO (October 17, 2018) –  Cannabis (also referred to as marijuana) has been available by prescription for a number of years in Canada, but with broader legalization, more interest has been raised on the subject.

Read More
CADTH Makes Deadly Decision for Some Cystic Fibrosis Patients in Canada
October 4, 2018

TORONTO (October 4 , 2018) – Today, the Canadian Agency for Drugs and Technologies in Health (CADTH) has recommended that the cost of cystic fibrosis (CF) drug ORKAMBI not be covered by provincial drug programs. Cystic Fibrosis Canada wholeheartedly disagrees with the decision and cautions that this could have deadly consequences for some Canadians with CF for years to come.

Read More